Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology

Despite the large body of evidence proving the efficacy and safety of SARS-CoV-2 vaccination, patients with certain neurological disorders still have a surprisingly high percentage of distrust and fear of adverse events. Our observations emphasize the importance of continuous evidence-based information delivery and patient education by treating neurologists.

Authors

Institutions

Publication Details

Journal
Neurological Sciences
Published
2025-02-04
DOI
https://doi.org/10.1007/s10072-025-08017-w
Citations
3
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
4.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology

Francesco Cavallieri, Sonja Hochmeister, Şerefnur Öztürk, Raimund Helbok et al.
3 citations
Neurological Sciences
SARS-CoV-2 and COVID-19 Research
4.19
article

Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology

Francesco Cavallieri, Sonja Hochmeister, Şerefnur Öztürk, Raimund Helbok, Martin Rakuša, Elena Moro, Johann Sellner, Alla Guekht, Alberto Priori, Barbara Willekens, Dániel Bereczki, Saša R. Filipović, Filippo Martinelli Boneschi, Alessandra Fanciulli, Dauren Ramankulov
article en
3 citations

Abstract

Despite the large body of evidence proving the efficacy and safety of SARS-CoV-2 vaccination, patients with certain neurological disorders still have a surprisingly high percentage of distrust and fear of adverse events. Our observations emphasize the importance of continuous evidence-based information delivery and patient education by treating neurologists.

Neurological SciencesVol. 46(4)
Semmelweis University (HU), Johannes Kepler University of Linz (AT), Selçuk University (TR), Innsbruck Medical University (AT), University of Antwerp (BE), Inserm (FR), University of Milan (IT), Universität Innsbruck (AT), Medical University of Graz (AT), Paracelsus Medical University (AT), Centre Hospitalier Universitaire de Grenoble (FR), TUM Klinikum (DE), European Academy of Neurology (AT), Pirogov Russian National Research Medical University (RU), University of Belgrade (RS), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Antwerp University Hospital (BE), Moscow Research and Clinical Center for Neuropsychiatry (RU), Christian Doppler Klinik (AT), Stadtkrankenhaus Schwabach (DE), Landesklinikum Korneuburg (AT), University Clinical Centre Maribor (SI), Karl Landsteiner University of Health Sciences (AT), Grenoble Institute of Neurosciences (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Technical University of Munich (DE), Université Grenoble Alpes (FR)
Good health and well-being
Openalex Percentile: Top 8%
SARS-CoV-2 and COVID-19 Research
4.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.